TBD Angels — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Yuva Bioscencesyuvabio.comFeb 2024 · $7.5M

Yuva Biosciences develops and licenses Y100, a cosmetic active ingredient that enhances mitochondrial health to reduce visible signs of aging for use in skincare and haircare products.

AI & Machine LearningBiotechConsumerHealthtechLongevityBirmingham, US

Greg Schmergel(Executive Officer, Director)

BoardFred Ehrsam(Director)Daniel Browne(Director)

Co-investorsInnovation Depot Measured Western Technology Investment VentureSouth

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.